Through this partnership, FIS will ensure the long-term availability of high-quality, pharmaceutical-grade furosemide active pharmaceutical ingredient (API), supporting SQ Innovation’s current products and future pipeline in the United States, Europe, and other global markets.
As a leading Italian manufacturer and one of Europe’s foremost API producers, we will be a key supply partner.
As our CEO, Daniele Piergentili, highlighted: “By combining our advanced manufacturing expertise with rigorous quality and regulatory standards, we can provide a strong, reliable supply foundation for this proven ingredient for innovative products, to the benefit of patients worldwide”.
To learn more, click here.